EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Menthol: An underestimated anticancer agent

Yijia Zhao, Huafeng Pan, Wei Liu, E Liu, Yaobin Pang, Hongjin Gao, Qingying He, Wenhao Liao, Yejing Yao, Jinhao Zeng, Jing Guo

Frontiers in Pharmacology · 17.03.2023 · 14

DOI: 10.3389/fphar.2023.1148790 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Frontiers in Pharmacology, online erschienen am 17.03.2023. Verfasst von Yijia Zhao und 10 weiteren Autor:innen. Beteiligte Einrichtung: Dermatological Department, Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, China. Die Arbeit wurde bisher 49-mal zitiert (Crossref) und nennt 123 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Menthol, a widely used natural, active compound, has recently been shown to have anticancer activity. Moreover, it has been found to have a promising future in the treatment of various solid tumors. Therefore, using literature from PubMed, EMBASE, Web of Science, Ovid, ScienceDirect, and China National Knowledge Infrastructure databases, the present study reviewed the anticancer activity of menthol and the underlying mechanism. Menthol has a good safety profile and exerts its anticancer activity via multiple pathways and targets. As a result, it has gained popularity for significantly inhibiting different types of cancer cells by various mechanisms such as induction of apoptosis, cell cycle arrest, disruption of tubulin polymerization, and inhibition of tumor angiogenesis. Owing to the excellent anticancer activity menthol has demonstrated, further research is warranted for developing it as a novel anticancer agent. However, there are limitations and gaps in the current research on menthol, and its antitumor mechanism has not been completely elucidated. It is expected that more basic experimental and clinical studies focusing on menthol and its derivatives will eventually help in its clinical application as a novel anticancer agent.

Schlagwörter

Stichwörter der Autor:innen

anticancerfuture directionmentholmolecular mechanismnatural product

Autor:innen und Institutionen

  • Dermatological Department, Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, China.
  • Science and Technology Innovation Center, Guangzhou University of Chinese Medicine, Guangzhou, China.
  • The First Affiliated Hospital, Guangzhou University of Chinese Medicine, Guangzhou, China.
  • Department of Gastroenterology, Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, China.
  • TCM Regulating Metabolic Diseases Key Laboratory of Sichuan Province, Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, China.

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Zhao, Y., Pan, H., Liu, W., Liu, E., Pang, Y., Gao, H., He, Q., Liao, W., Yao, Y., Zeng, J., & Guo, J. (2023). Menthol: An underestimated anticancer agent. Frontiers in Pharmacology, 14. https://doi.org/10.3389/fphar.2023.1148790

Vancouver

Zhao Y, Pan H, Liu W, Liu E, Pang Y, Gao H, et al. Menthol: An underestimated anticancer agent. Frontiers in Pharmacology. 2023;14. doi:10.3389/fphar.2023.1148790

BibTeX
@article{Zhao2023,
  author = {Zhao, Yijia and Pan, Huafeng and Liu, Wei and Liu, E and Pang, Yaobin and Gao, Hongjin and He, Qingying and Liao, Wenhao and Yao, Yejing and Zeng, Jinhao and Guo, Jing},
  title = {Menthol: An underestimated anticancer agent},
  journal = {Frontiers in Pharmacology},
  year = {2023},
  volume = {14},
  doi = {10.3389/fphar.2023.1148790}
}
Kostenlos starten →